Submit Deal

ADAPTIMMUNE THERAPEUTICS PLC

HQ - Oxford

Summary

Adaptimmune is a biopharmaceutical company that develops T cell therapies against cancer.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 41 M

Avg. Deal Size£ 41 M

Market Context

Senior Management

Sort

Target: TCR² THERAPEUTICS INC

Bidder: ADAPTIMMUNE THERAPEUTICS PLC

9 Service Providers

23 Dealmakers

n/a

Value

Target: ADAPTIMMUNE [FOUR CELL THERAPY ASSETS]

Bidder: US WORLDMEDS

8 Service Providers

17 Dealmakers

£ 40 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy